Stephan Toutain
Direttore operativo presso PDS BIOTECHNOLOGY CORPORATION
Posizioni attive di Stephan Toutain
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Direttore operativo | 01/05/2024 | - |
Storia della carriera di Stephan Toutain
Precedenti posizioni note di Stephan Toutain
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Direttore operativo | 05/03/2018 | 01/04/2024 |
| INTERLEUKIN GENETICS, INC | Corporate Officer/Principal | 01/07/2016 | 01/08/2017 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2014 | 01/01/2015 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2009 | 01/01/2011 |
Formazione di Stephan Toutain
| The University of North Carolina at Charlotte | Masters Business Admin |
| Nancy-Université | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Francia | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 2 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ANAVEX LIFE SCIENCES CORP. | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| PDS BIOTECHNOLOGY CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Stephan Toutain
- Esperienza
